Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 10/20 | 0.56 |
| ▸ | CALCR | P30988 | 10/20 | 0.56 |
| ▸ | NPY2R | P49146 | 7/20 | 0.55 |
| ▸ | NPY4R | P50391 | 7/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.55 |
| ▸ | NPY1R | P25929 | 5/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31307235 | 0.90 | RAMP3 (0.57) | RAMP3CALCR | |
| SCHEMBL31276526 | 0.90 | RAMP3 (0.58) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29680011 | 0.89 | RAMP3 (0.56) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30429353 | 0.89 | RAMP3 (0.56) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29570058 | 0.89 | NPY2R (0.54) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30495746 | 0.88 | NPY2R (0.58) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29680080 | 0.88 | RAMP3 (0.56) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30431765 | 0.88 | NPY2R (0.60) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL31031621 | 0.87 | NPY2R (0.58) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29679604 | 0.87 | RAMP3 (0.57) | RAMP3CALCRNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024211576-A1 | IMMUNOTHERAPY FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-10 | — | — | WO | claimed |
| CN-115894139-A | High-solid-content high-combustion-rate butylated hydroxytoluene composite solid propellant and preparation method thereof | 湖北三江航天江河化工科技有限公司 | 2023-04-04 | — | — | CN | claimed |
| US-20260137088-A1 | COMPOSITIONS OF ENDOPHYTES AND SYNTHETIC ENDOPHYTE CONSORTIA FOR IMPROVING NITROGEN AND PHOSPHORUS UPTAKE, NUTRITION, GROWTH, AND PERFORMANCE IN PLANTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF WASHINGTON | 2026-05-21 | — | — | US | disclosed |
| US-12599141-B2 | Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-04-14 | — | — | US | disclosed |
| US-20260085090-A1 | METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY | GENENTECH, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| US-12570957-B2 | Isolated naive pluripotent stem cells and methods of generating same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2026-03-10 | — | — | US | disclosed |
| US-20260028583-A1 | ISOLATED NAIVE PLURIPOTENT STEM CELLS AND METHODS OF GENERATING SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2026-01-29 | — | — | US | disclosed |
| US-12533637-B2 | Biochar-anaerobic membrane biological treatment system and process | XI'AN UNIVERSITY OF ARCHITECTURE AND TECHNOLOGY (CN) | 2026-01-27 | — | — | US | disclosed |
| US-12503487-B2 | Method for the reduction of host cell proteins in affinity chromatography | GENENTECH, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| WO-2025233437-A1 | POLYPEPTIDE COMPRISING A CAPSID PROTEIN SEQUENCE | A-SPECTAR GMBH (AT) | 2025-11-13 | — | — | WO | disclosed |
| EP-4647438-A1 | POLYPEPTIDE COMPRISING A CAPSID PROTEIN SEQUENCE | A-Spectar GmbH (AT) | 2025-11-12 | — | — | EP | disclosed |
| US-20220169675-A1 | Method for the reduction of host cell proteins in affinity chromatography | GENENTECH, INC. (US) | 2022-06-02 | — | — | US | disclosed |
| CN-114507108-A | Carborane plasticized boron-containing fuel-rich propellant | 湖北航天化学技术研究所 | 2022-05-17 | — | — | CN | disclosed |
| WO-2022086019-A1 | A PURIFIED EXTRACT ISOLATED FROM AGRIMONIA COREANA NAKAI CONTAINING ABUNDANT AMOUNT OF ACTIVE INGREDIENT, THE PREPARATION THEREOF, THE COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFLAMMATION, ALLERGY AND ATOPIC DERMATITIS AND THE USE THEREOF | DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2022-04-28 | — | — | WO | disclosed |
| US-20220119499-A1 | Method for the reduction of host cell proteins in affinity chromatography | HOFFMANN-LA ROCHE INC. (US) | 2022-04-21 | — | — | US | disclosed |
| CN-112898106-B | High-burning-rate propellant for platform combustion and preparation method thereof | 湖北航天化学技术研究所 | 2022-04-08 | — | — | CN | disclosed |
| WO-2022072926-A1 | METHODS FOR THE PRODUCTION OF NICKEL (II) ETIOPORPHYRIN-I | ADGERO BIOPHARMACEUTICALS HOLDINGS INC. (US) | 2022-04-07 | — | — | WO | disclosed |
| CN-114174244-A | Ignition booster composition | 奥托立夫ASP公司 | 2022-03-11 | — | — | CN | disclosed |
| WO-2022029499-A1 | METHODS OF TREATING REFRACTORY ASCITES | ADS AIPHIA DEVELOPMENT SERVICES AG (CH) | 2022-02-10 | — | — | WO | disclosed |
| WO-2022029497-A1 | ULARITIDE FOR USE IN METHODS OF TREATING REFRACTORY ASCITES | ADS AIPHIA DEVELOPMENT SERVICES AG (CH) | 2022-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028583-A1 | ISOLATED NAIVE PLURIPOTENT STEM CELLS AND METHODS OF GENERATING SAME | PRKD3, GSK3B, GSK3A | RAMP3 1266/4885CALCR 3650/4885NPY2R 2488/4885 |
| US-20260137088-A1 | COMPOSITIONS OF ENDOPHYTES AND SYNTHETIC ENDOPHYTE CONSORTIA FOR IMPROVING NITROGEN AND PHOSPHORUS UPTAKE, NUTRITION, GROWTH, AND PERFORMANCE IN PLANTS AND METHODS OF MAKING AND USING THE SAME | PPP6R3, PPP6R1, SLC6A4 | RAMP3 3645/4885CALCR 4258/4885NPY2R 659/4885 |
| US-12570957-B2 | Isolated naive pluripotent stem cells and methods of generating same | GSK3B, EZH2, GSK3A | RAMP3 3722/4885CALCR 4520/4885NPY2R 2228/4885 |
| US-12599141-B2 | Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications | PRNP, PCNP, VIM | RAMP3 913/4885CALCR 3628/4885NPY2R 1654/4885 |
| US-20260085090-A1 | METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY | LYPLAL1, CMBL, AGBL2 | RAMP3 1009/4885CALCR 1430/4885NPY2R 3989/4885 |
| US-12533637-B2 | Biochar-anaerobic membrane biological treatment system and process | ATP5ME, ATP5MK, PGLS | RAMP3 2543/4885CALCR 634/4885NPY2R 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.